Atlas Trials

Radioembolization With Intra-arterial Angiotensin II to Improve Tumor-absorbed Dose (RADIANT)

Clinical trial NCT07312292 · RECRUITING

Trial details

NCT number
NCT07312292
Sponsor
Niek Wijnen
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Liver Cancer (Locally Advanced or Metastatic)Liver Cancer Adult
Start date
2026-01-01
Primary completion
2027-05-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.